SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-152416
Filing Date
2024-06-03
Accepted
2024-06-03 08:39:32
Documents
10
Effectiveness Date
2024-06-03

Document Format Files

Seq Description Document Type Size
1 S-3ASR d811721ds3asr.htm S-3ASR 236858
2 EX-4.4 d811721dex44.htm EX-4.4 436498
3 EX-5.1 d811721dex51.htm EX-5.1 19993
4 EX-5.2 d811721dex52.htm EX-5.2 47951
5 EX-23.1 d811721dex231.htm EX-23.1 1794
6 EX-25.1 d811721dex251.htm EX-25.1 131358
7 EX-25.2 d811721dex252.htm EX-25.2 134953
8 EX-FILING FEES d811721dexfilingfees.htm EX-FILING FEES 50625
9 GRAPHIC g811721dsp108.jpg GRAPHIC 1995
10 GRAPHIC g811721g11a11.jpg GRAPHIC 13415
  Complete submission text file 0001193125-24-152416.txt   1083160
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-279905 | Film No.: 241012102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 212-883-0200
Royalty Pharma Holdings Ltd. (Filer) CIK: 0001868134 (see all company filings)

IRS No.: 981526515 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-279905-01 | Film No.: 241012103